Several ongoing trials are focusing in particular on PUFAs: among them, the trial NCT03926351 is investigating the role of high-dose DHA in patients at risk for dementia, while the trial NCT03613844 is further investigating the association between the presence of the APOE ε4 allele and the and the reduced delivery of DHA to the brain. This evidence concerns the gene APOE and dementia.